Clinical Trials Logo

Clinical Trial Summary

Phase I/II, single center, prospective, open-label, non-controlled, non-randomized, interventional, cohort study in which low risk living donor liver transplant (LDLT) recipients will receive a single infusion of donor-derived DCreg 1 week prior to transplantation. All patients will be maintained on MPA and Tacrolimus (Tac) for the 1st 6 months after transplantation. At that time point, recipients meeting specific criteria will be slowly weaned off MPA per standard of care over a period of 6 months. Participants will then be evaluated for TAC weaning at 1 yr after transplantation. Those who meet specific criteria be weaned off Tac over 6 months . Successfully weaned participants who remain rejection-free will undergo 3 years of follow-up after the last dose of immunosuppression.


Clinical Trial Description

Phase I/II, single center, prospective, open-label, non-controlled, non-randomized, interventional, cohort study in which low risk living donor liver transplant (LDLT) recipients will receive a single infusion of donor-derived DCreg with concurrent mycophenolic acid (MPA) therapy (1/2 dose) 1 week prior to transplantation. All patients will be maintained on MPA and Tacrolimus (Tac) for the 1st 6 months after transplantation. At that time point, recipients meeting specific criteria (no rejection and permissive liver function tests (LFTs)) will be slowly weaned off MPA per standard of care over a period of 6 months. Participants will then be evaluated for TAC weaning at 1 yr after transplantation. Those who meet the criteria of no rejection and permissive LFTs will undergo a protocol liver biopsy and proceed to Tac weaning over 6 months if liver biopsy is permissive. Successfully weaned participants who remain rejection-free will undergo 3 years of follow-up after the last dose of immunosuppression. They will undergo a liver biopsy at 1 yr and 3 yrs after immunosuppression withdrawal. Participants who are removed from the study protocol at any time will return to standard of care but will continue to be followed by the study team and may undergo a liver biopsy at the end of the study (4.5 yrs after transplantation). For subjects who return to standard of care (on immunosuppression at end of study), the year 4.5 biopsy will be optional. ;


Study Design


Related Conditions & MeSH terms

  • Living Donor Liver Transplantation

NCT number NCT03164265
Study type Interventional
Source University of Pittsburgh
Contact
Status Active, not recruiting
Phase Phase 1/Phase 2
Start date August 30, 2017
Completion date December 2024

See also
  Status Clinical Trial Phase
Completed NCT01144312 - Population Pharmacokinetics of Fentanyl in Patients Undergoing Living Donor Liver Transplantation N/A
Completed NCT00994981 - Magnesium Administration in Liver Transplantation and Reperfusion Injury Phase 4
Not yet recruiting NCT04988100 - Impact of Splenic Artery Ligation in LDLT for Patients With Portal Hypertension N/A
Completed NCT05506020 - Application of ICG Fluorescence Cholangiography in Laparoscopic Living Donor Left Lateral Sectionectomy N/A
Recruiting NCT05431361 - PRehab tO PreparE Living Liver Donors for Enhanced Recovery N/A
Recruiting NCT04909645 - A Comparison of Invasive and Non-invasive Measurement of CI and SVR in Liver Transplantation N/A
Recruiting NCT01907750 - Transcystic Versus Transanastomotic Tube Drainage in Right Lobe LDLT Phase 3
Completed NCT04184401 - Effect of Ascites Replacement Strategy on Time to 1st Flatus After LDLT Phase 4
Completed NCT02990351 - Efficacy of Loco-regional Treatment for Hepatocellular Carcinoma Prior to Living Donor Liver Transplantation in Egypt N/A
Active, not recruiting NCT04208919 - Delayed Infusion of DCreg in Living Donor Liver Transplantation Phase 1/Phase 2
Completed NCT03773276 - Norepinephrine Boluses in Liver Transplantation Phase 1/Phase 2
Completed NCT05010941 - Hypotension Prediction Index in Living Donor Liver Transplantation
Not yet recruiting NCT04943263 - A Comparison of Temperature Measurement During Living Donor Liver Transplantation N/A